Carnicelli, A. P., De Caterina, R., Halperin, J. L., Renda, G., Ruff, C. T., Trevisan, M., … ENGAGE AF-TIMI 48 Investigators, . (2017). Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves. Circulation, 135(13), 1273–1275. https://doi.org/10.1161/circulationaha.116.026714

Carnicelli, Anthony P., Raffaele De Caterina, Jonathan L. Halperin, Giulia Renda, Christian T. Ruff, Marco Trevisan, Francesco Nordio, et al. “Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves.” Circulation 135, no. 13 (March 2017): 1273–75. https://doi.org/10.1161/circulationaha.116.026714.

Carnicelli AP, De Caterina R, Halperin JL, Renda G, Ruff CT, Trevisan M, et al. Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves. Circulation. 2017 Mar;135(13):1273–5.

Carnicelli, Anthony P., et al. “Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves.” Circulation, vol. 135, no. 13, Mar. 2017, pp. 1273–75. Epmc, doi:10.1161/circulationaha.116.026714.

Carnicelli AP, De Caterina R, Halperin JL, Renda G, Ruff CT, Trevisan M, Nordio F, Mercuri MF, Antman E, Giugliano RP, ENGAGE AF-TIMI 48 Investigators. Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves. Circulation. 2017 Mar;135(13):1273–1275.